Expert Opinion on Psychiatry

About this Collection

Cover image of Psychiatry collection

 

The Expert Opinion collections are online feeds that group together

articles published from across the Expert Opinion series by therapy

area. Articles from 2011 onwards are included.

 

Expert Opinion on Psychiatry covers all areas of the R&D pipeline  and provides insight into schizophrenia, ADHD, depression, autism, bipolar disorder and anxiety disorders, together with antipsychotics, benzodiazepines and other therapeutic approaches.

 












All Articles

Showing 1 to 20 of 179 Articles Left arrow
Previous page
Next page
Right arrow
Order results by:
Newest

Oldest

Most Read

Alert me when new articles are published in this collection

 

Selected Add to Favourites |
View Summaries |
Download Citation


1.
Fluoxetine: a case history of its discovery and preclinical development

Laura Perez-Caballero, Sonia Torres-Sanchez, Lidia Bravo, Juan Antonio Mico, Esther Berrocoso

Expert Opinion on Drug Discovery May 2022, Vol. 9, No. 5, Pages 567-578
Summary | Full Text | PDF (417 KB) | PDF Plus (515 KB)
|
Add to Favourites
| Related 


2.
Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia

Larry Alphs, Cynthia A Bossie, Dong-Jing Fu, Yi-Wen Ma, Jennifer Kern Sliwa

Expert Opinion on Pharmacotherapy May 2022, Vol. 15, No. 7, Pages 1029-1042
Summary | Full Text | PDF (571 KB) | PDF Plus (573 KB)
|
Add to Favourites
| Related 


3.
Pharmacokinetic evaluation of vortioxetine for the treatment of major depressive disorder

Steven L Dubovsky

Expert Opinion on Drug Metabolism & Toxicology May 2022, Vol. 10, No. 5, Pages 759-766
Summary | Full Text | PDF (293 KB) | PDF Plus (320 KB)
|
Add to Favourites
| Related 


4.
Clinically relevant interactions between newer antidepressants and second-generation antipsychotics

Edoardo Spina, Jose de Leon

Expert Opinion on Drug Metabolism & Toxicology May 2022, Vol. 10, No. 5, Pages 721-746
Summary | Full Text | PDF (684 KB) | PDF Plus (790 KB)
|
Add to Favourites
| Related 


5.
Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review

Marc De Hert, Johan Detraux, Joseph Peuskens

Expert Opinion on Drug Safety May 2022, Vol. 13, No. 5, Pages 605-624
Summary | Full Text | PDF (382 KB) | PDF Plus (496 KB)
|
Add to Favourites
| Related 


6.
Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder

Massimiliano Buoli, Massimo Carlo Mauri, Alfredo Carlo Altamura

Posted online on 9 Apr 2022.

Summary | Full Text | PDF (268 KB) | PDF Plus (316 KB)
|
Add to Favourites
| Related 


7.
Serotonergic antidepressants and perioperative bleeding risk: a systematic review

Artin A Mahdanian, Soham Rej, Simon L Bacon, Deniz Ozdin, Kim L Lavoie, Karl Looper

Posted online on 9 Apr 2022.

Summary | Full Text | PDF (275 KB) | PDF Plus (277 KB)
|
Add to Favourites
| Related 


8.
Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal

Rebecca L Ashare, Heath D Schmidt

Posted online on 7 Apr 2022.

Summary | Full Text | PDF (343 KB) | PDF Plus (345 KB)
|
Add to Favourites
| Related 


9.
Fresh approaches to antidepressant drug discovery

Christoph Anacker

Expert Opinion on Drug Discovery Apr 2022, Vol. 9, No. 4, Pages 407-421
Summary | Full Text | PDF (312 KB) | PDF Plus (435 KB)
|
Add to Favourites
| Related 


10.
Paliperidone extended-release in patients with non-acute schizophrenia previously unsuccessfully treated with other oral antipsychotics

Andreas Schreiner, Marjolein Lahaye, Joseph Peuskens, Dieter Naber, Nesrin Dilbaz, Bruno Millet, Manuel A Franco, Elmars Rancans, Jacek Turczynski, Enrico Smeraldi, Elsa Lara, Nikolaj G Neznanov

Expert Opinion on Pharmacotherapy Apr 2022, Vol. 15, No. 5, Pages 593-603
Summary | Full Text | PDF (417 KB) | PDF Plus (419 KB)
|
Add to Favourites
| Related 


11.
Agomelatine: a new option for treatment of depression?

Chi-Un Pae

Expert Opinion on Pharmacotherapy Mar 2022, Vol. 15, No. 4, Pages 443-447
Summary | Full Text | PDF (156 KB) | PDF Plus (158 KB)
|
Add to Favourites
| Related 


12.
Current pharmacological treatment approaches for alcohol dependence

Christian A Müller, Olga Geisel, Roman Banas, Andreas Heinz

Expert Opinion on Pharmacotherapy Mar 2022, Vol. 15, No. 4, Pages 471-481
Summary | Full Text | PDF (253 KB) | PDF Plus (255 KB)
|
Add to Favourites
| Related 


13.
An intricate relationship between pain and depression: clinical correlates, coactivation factors and therapeutic targets

Kanwaljit Chopra, Vipin Arora

Expert Opinion on Therapeutic Targets Feb 2022, Vol. 18, No. 2, Pages 159-176
Summary | Full Text | PDF (785 KB) | PDF Plus (787 KB)
|
Add to Favourites
| Related 


14.
Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention

Katrin Skala, Fabio Caputo, Antonio Mirijello, Gabriele Vassallo, Mariangela Antonelli, Anna Ferrulli, Henriette Walter, Otto Lesch, Giovanni Addolorato

Expert Opinion on Pharmacotherapy Feb 2022, Vol. 15, No. 2, Pages 245-257
Summary | Full Text | PDF (501 KB) | PDF Plus (503 KB)
|
Add to Favourites
| Related 


15.
Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials

Naren P Rao, Gary Remington

Expert Opinion on Pharmacotherapy Feb 2022, Vol. 15, No. 3, Pages 373-383
Summary | Full Text | PDF (510 KB) | PDF Plus (512 KB)
|
Add to Favourites
| Related 


16.
The mechanism, efficacy, and tolerability profile of agomelatine

Sarah E MacIsaac, André F Carvalho, Danielle S Cha, Rodrigo B Mansur, Roger S McIntyre

Expert Opinion on Pharmacotherapy Feb 2022, Vol. 15, No. 2, Pages 259-274
Summary | Full Text | PDF (254 KB) | PDF Plus (256 KB)
|
Add to Favourites
| Related 


17.
Antidepressant and QT interval prolongation, how should we look at this issue? Focus on citalopram

Chi-Un Pae, Sheng-Min Wang, Soo-Jung Lee, Changsu Han, Ashiwn A Patkar, Prakash S Masand

Expert Opinion on Drug Safety Feb 2022, Vol. 13, No. 2, Pages 197-205
Summary | Full Text | PDF (217 KB) | PDF Plus (268 KB)
|
Add to Favourites
| Related 


18.
Tricyclic antidepressants in pregnancy and puerperium

Salvatore Gentile

Expert Opinion on Drug Safety Feb 2022, Vol. 13, No. 2, Pages 207-225
Summary | Full Text | PDF (303 KB) | PDF Plus (379 KB)
|
Add to Favourites
| Related 


19.
Safety profile of iloperidone in the treatment of schizophrenia

Navin V Dargani, Anil K Malhotra

Expert Opinion on Drug Safety Feb 2022, Vol. 13, No. 2, Pages 241-246
Summary | Full Text | PDF (230 KB) | PDF Plus (257 KB)
|
Add to Favourites
| Related 


20.
Anxiolytic drug discovery: what are the novel approaches and how can we improve them?

Adam Michael Stewart, Allan V Kalueff

Expert Opinion on Drug Discovery Jan 2022, Vol. 9, No. 1, Pages 15-26
Summary | Full Text | PDF (355 KB) | PDF Plus (357 KB)
|
Add to Favourites
| Related 

Showing 1 to 20 of 179 Articles Left arrow
Previous page
Next page
Right arrow